Robin Wagner
Ufficiale delle Risorse Umane presso KEROS THERAPEUTICS, INC.
Profilo
Robin Wagner is currently the Vice President-Human Resources at Keros Therapeutics, Inc. Prior to this, Ms. Wagner worked as a Principal at Genzyme Therapeutics Ltd.
and Karyopharm Therapeutics, Inc. Ms. Wagner completed their undergraduate degree at the University of Hartford.
Posizioni attive di Robin Wagner
| Società | Posizione | Inizio |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 01/06/2021 |
Precedenti posizioni note di Robin Wagner
| Società | Posizione | Fine |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Robin Wagner
| University of Hartford | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KEROS THERAPEUTICS, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Robin Wagner
